These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 34670613)

  • 1.
    Saffari A; Cannet C; Blaschek A; Hahn A; Hoffmann GF; Johannsen J; Kirsten R; Kockaya M; Kölker S; Müller-Felber W; Roos A; Schäfer H; Schara U; Spraul M; Trefz FK; Vill K; Wick W; Weiler M; Okun JG; Ziegler A
    Orphanet J Rare Dis; 2021 Oct; 16(1):441. PubMed ID: 34670613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress in treatment and newborn screening for Duchenne muscular dystrophy and spinal muscular atrophy.
    Ke Q; Zhao ZY; Mendell JR; Baker M; Wiley V; Kwon JM; Alfano LN; Connolly AM; Jay C; Polari H; Ciafaloni E; Qi M; Griggs RC; Gatheridge MA
    World J Pediatr; 2019 Jun; 15(3):219-225. PubMed ID: 30904991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinal Muscular Atrophy: An Evolving Scenario through New Perspectives in Diagnosis and Advances in Therapies.
    Angilletta I; Ferrante R; Giansante R; Lombardi L; Babore A; Dell'Elice A; Alessandrelli E; Notarangelo S; Ranaudo M; Palmarini C; De Laurenzi V; Stuppia L; Rossi C
    Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoring Protein Expression in Neuromuscular Conditions: A Review Assessing the Current State of Exon Skipping/Inclusion and Gene Therapies for Duchenne Muscular Dystrophy and Spinal Muscular Atrophy.
    Sheikh O; Yokota T
    BioDrugs; 2021 Jul; 35(4):389-399. PubMed ID: 34097287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of gene therapy in spinal muscular atrophy and Duchenne muscular dystrophy.
    Abreu NJ; Waldrop MA
    Pediatr Pulmonol; 2021 Apr; 56(4):710-720. PubMed ID: 32886442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated Approaches and Practical Recommendations in Patient Care Identified with 5q Spinal Muscular Atrophy through Newborn Screening.
    Romanelli Tavares VL; Mendonça RH; Toledo MS; Hadachi SM; Grindler CM; Zanoteli E; Marques W; Oliveira ASB; Breinis P; Morita MDPA; França MC
    Genes (Basel); 2024 Jun; 15(7):. PubMed ID: 39062637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parental attitudes toward newborn screening for Duchenne/Becker muscular dystrophy and spinal muscular atrophy.
    Wood MF; Hughes SC; Hache LP; Naylor EW; Abdel-Hamid HZ; Barmada MM; Dobrowolski SF; Stickler DE; Clemens PR
    Muscle Nerve; 2014 Jun; 49(6):822-8. PubMed ID: 24307279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo proton magnetic resonance spectroscopy assessment for muscle metabolism in neuromuscular diseases.
    Hsieh TJ; Wang CK; Chuang HY; Jong YJ; Li CW; Liu GC
    J Pediatr; 2007 Sep; 151(3):319-21. PubMed ID: 17719948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal molecular diagnosis of inherited neuromuscular diseases: Duchenne/Becker muscular dystrophy, myotonic dystrophy type 1 and spinal muscular atrophy.
    Esposito G; Ruggiero R; Savarese M; Savarese G; Tremolaterra MR; Salvatore F; Carsana A
    Clin Chem Lab Med; 2013 Dec; 51(12):2239-45. PubMed ID: 23729582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Denaturing high-performance liquid chromatography coupled with multiplex PCR for rapid detection of large duplications or deletions in patients with Duchenne muscular dystrophy and spinal muscular atrophy].
    Zou HQ; Zhao BJ; Yan J; Han W; Xiong MH; Peng KR
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Dec; 29(6):686-9. PubMed ID: 23225050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomics profiling of urine reveals specific titin fragments as biomarkers of Duchenne muscular dystrophy.
    Rouillon J; Zocevic A; Leger T; Garcia C; Camadro JM; Udd B; Wong B; Servais L; Voit T; Svinartchouk F
    Neuromuscul Disord; 2014 Jul; 24(7):563-73. PubMed ID: 24813925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-body vibration training in children with Duchenne muscular dystrophy and spinal muscular atrophy.
    Vry J; Schubert IJ; Semler O; Haug V; Schönau E; Kirschner J
    Eur J Paediatr Neurol; 2014 Mar; 18(2):140-9. PubMed ID: 24157400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why should a 5q spinal muscular atrophy neonatal screening program be started?
    Becker MM; Nardes F; Dangouloff T; Servais L; Araujo APQC; Gurgel-Giannetti J
    Arq Neuropsiquiatr; 2024 Oct; 82(10):1-9. PubMed ID: 39396519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurofilament light protein as a biomarker for spinal muscular atrophy: a review and reference ranges.
    Bayoumy S; Verberk IMW; Vermunt L; Willemse E; den Dulk B; van der Ploeg AT; Pajkrt D; Nitz E; van den Hout JMP; van der Post J; Wolf NI; Beerepoot S; Groen EJN; Tüngler V; Teunissen CE
    Clin Chem Lab Med; 2024 Jun; 62(7):1252-1265. PubMed ID: 38215341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validity of the EK scale: a functional assessment of non-ambulatory individuals with Duchenne muscular dystrophy or spinal muscular atrophy.
    Steffensen B; Hyde S; Lyager S; Mattsson E
    Physiother Res Int; 2001; 6(3):119-34. PubMed ID: 11725594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurological and Psychiatric Aspects of Biological Markers for the Provision of Medical Care to Patients with Spinal Muscular Atrophy 5q.
    Gayduk AJ; Syunyakov T; Gazheva AV; Strelnik A; Chigareva O; Kuznetsov A; Kokorev D; Sustretov A; Cumming P; Vlasov YV
    Psychiatr Danub; 2023 Oct; 35(Suppl 2):322-328. PubMed ID: 37800249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship Between Hand Strength and Function in Duchenne Muscular Dystrophy and Spinal Muscular Atrophy: Implications for Clinical Trials.
    Decostre V; De Antonio M; Servais L; Hogrel JY
    J Neuromuscul Dis; 2024; 11(4):777-790. PubMed ID: 38788084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Upper limb functional assessment scale for children with Duchenne muscular dystrophy and Spinal muscular atrophy].
    Escobar RG; Lucero N; Solares C; Espinoza V; Moscoso O; Olguín P; Muñoz KT; Rosas R
    Rev Chil Pediatr; 2017 Feb; 88(1):92-99. PubMed ID: 28288228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The implementation of newborn screening for spinal muscular atrophy: the Australian experience.
    Kariyawasam DST; Russell JS; Wiley V; Alexander IE; Farrar MA
    Genet Med; 2020 Mar; 22(3):557-565. PubMed ID: 31607747
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.